{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q96BR1",
      "entity_text" : "SGK3",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ07407",
      "entity_text" : "PI3K inhibitor",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Moreover, a structurally distinct selective class I PI3K inhibitor that is in clinical trials termed BKM120 [XREF_BIBR] induced a comparable ~ 40% inhibition of SGK3 (XREF_FIG B).",
  "reading_complete" : "2020-08-08T19:55:55Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T19:47:15Z",
  "trigger" : "induced",
  "evidence" : [ "PI3K inhibitor that is in clinical trials termed BKM120 [ XREF_BIBR ] induced a comparable ~40% inhibition of SGK3" ],
  "pmc_id" : "4209782",
  "score" : 0
}